These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 27259892)

  • 1. [Protection against HIV - but only with good compliance!].
    Oberhofer E
    MMW Fortschr Med; 2016 Jun; 158 Suppl 1():11. PubMed ID: 27259892
    [No Abstract]   [Full Text] [Related]  

  • 2. Murnane, Coley, and Baeten respond to "every good randomization deserves observation".
    Murnane PM; Coley RY; Baeten JM
    Am J Epidemiol; 2015 Nov; 182(10):861-2. PubMed ID: 26487341
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacologic-Based Methods of Adherence Assessment in HIV Prevention.
    Brooks KM; Anderson PL
    Clin Pharmacol Ther; 2018 Dec; 104(6):1056-1059. PubMed ID: 30178462
    [No Abstract]   [Full Text] [Related]  

  • 4. [Not Available].
    Nau JY
    Rev Med Suisse; 2016 Aug; 12(526):1346-1347. PubMed ID: 28671781
    [No Abstract]   [Full Text] [Related]  

  • 5. HOW DO I PAY FOR PrEP?
    Evans D
    Posit Aware; 2015; 27(5):18-9. PubMed ID: 26714339
    [No Abstract]   [Full Text] [Related]  

  • 6. MOVING FORWARD WITH PrEP. THE BASICS OF PrEP.
    Highleyman L
    Posit Aware; 2015; 27(5):2-3. PubMed ID: 26714333
    [No Abstract]   [Full Text] [Related]  

  • 7. Invited commentary: every good randomization deserves observation.
    Westreich D; Edwards JK
    Am J Epidemiol; 2015 Nov; 182(10):857-60. PubMed ID: 26487342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress and pitfalls in measuring HIV preexposure prophylaxis coverage in the United States.
    Rosenberg ES; Marcus JL
    Ann Epidemiol; 2018 Dec; 28(12):830-832. PubMed ID: 30224292
    [No Abstract]   [Full Text] [Related]  

  • 9. Truvada (emtricitabine/tenofovir) pre-exposure prophylaxis roll-out among South African university students: Lots of positives, but let us keep an eye on possible surprises.
    Montjane K; Dlamini S; Dandara C
    S Afr Med J; 2018 Feb; 108(2):79-81. PubMed ID: 29429434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethical considerations for new HIV prevention trials.
    Sugarman J; Celum CL; Donnell D; Mayer KH
    Lancet HIV; 2019 Aug; 6(8):e489-e491. PubMed ID: 31221591
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatitis B virus reactivation or reinfection in a FEM-PrEP participant: a case report.
    Malahleha M; Ahmed K; Deese J; Nanda K; van Damme L; De Baetselier I; Burnett RJ
    J Med Case Rep; 2015 Sep; 9():207. PubMed ID: 26411737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HIV pre-exposure prophylaxis does not increase the rate of STI].
    Blondel N
    Rev Med Suisse; 2016 Jan; 12(503):236. PubMed ID: 26939198
    [No Abstract]   [Full Text] [Related]  

  • 13. HIV moments and pre-exposure prophylaxis.
    Grant RM; Glidden DV
    Lancet; 2016 Apr; 387(10027):1507-1508. PubMed ID: 27115970
    [No Abstract]   [Full Text] [Related]  

  • 14. ACP Journal Club. Preexposure tenofovir-emtricitabine reduced HIV infection in men who have unprotected anal sex with men.
    Sacks HS
    Ann Intern Med; 2016 Jan; 164(2):JC3. PubMed ID: 26784493
    [No Abstract]   [Full Text] [Related]  

  • 15. Infection: PrEParation to be PROUD of.
    Stone L
    Nat Rev Urol; 2015 Nov; 12(11):596. PubMed ID: 26439506
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiretroviral chemoprophylaxis: PROUD and pragmatism.
    Mayer KH; Beyrer C
    Lancet; 2016 Jan; 387(10013):6-7. PubMed ID: 26364262
    [No Abstract]   [Full Text] [Related]  

  • 17. Informal PrEP: an emerging need for nomenclature.
    Brisson J; Ravitsky V; Williams-Jones B
    Lancet Public Health; 2019 Feb; 4(2):e83. PubMed ID: 30578132
    [No Abstract]   [Full Text] [Related]  

  • 18. Feasibility of HIV Pre-Exposure Prophylaxis as Part of Routine Care in Toronto, Canada.
    Rajchgot J; Siemieniuk RA; Sivachandran N; Murphy P; Sharp A; Cicci A; Bogoch II
    J Acquir Immune Defic Syndr; 2016 Jul; 72(3):e80-1. PubMed ID: 27035886
    [No Abstract]   [Full Text] [Related]  

  • 19. HIV moments and pre-exposure prophylaxis--Authors' reply.
    Dunn DT; Gafos M; White E; McCormack S
    Lancet; 2016 Apr; 387(10027):1508. PubMed ID: 27115971
    [No Abstract]   [Full Text] [Related]  

  • 20. PrEP and the PrEPstars.
    Morgan J
    Lancet HIV; 2018 Nov; 5(11):e616. PubMed ID: 30104178
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.